Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
| Date | 7th, Aug 2020 |
|---|---|
| Source | Nanowerk - Nanotechnology Websites |
DESCRIPTION
Researchers successfully developed a nanomedicine-based strategy for chemo-immunotherapy of glioblastoma, which has the worst prognosis among brain tumors.